FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Global Health Limited Stock AnalysisComprehensive stock analysis for Global Health Limited (GLH.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisGLH.AX
GLH.AX
Global Health Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
GLH.AX
Home🔹Stocks🔹Global Health Limited

Global Health Limited

GLH.AX•ASX

Global Health Limited

GLH.AX•ASX
Sentiment

Your view on GLH.AX

Sentiment
Your view
GLH.AX
Global Health Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
GLH.AX
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Global Health Limited

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Alumootil Mathew Ravi Cherian
Headquarters
696 Bourke Street, Melbourne, VIC, AU
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Alumootil Mathew Ravi Cherian
Headquarters
696 Bourke Street, Melbourne, VIC, AU
Description

Headquartered in Melbourne, Australia, and established in 1985, Global Health Limited develops and supplies digital health solutions for the Australian healthcare sector. Their comprehensive suite of software addresses various needs, including specialized platforms for mental health practitioners like psychologists and psychiatrists. The company provides integrated solutions across community health and human services, encompassing areas such as drug and alcohol support, disability services, post-acute and community care, and rehabilitation. Furthermore, they offer solutions for home and aged care, general practice, pharmacies, and consumer engagement. Key products include the MasterCare Electronic Medical Record (EMR), MasterCare + for digitizing services, and MasterCare Patient Administration System (PAS). PrimaryClinic provides medical and practice management capabilities for GPs and specialists, enabling shared patient demographic data. Other significant tools are ReferralNet for secure document exchange, LifeCard as a personal health record, and HotHealth for digital patient engagement. Complementing these are the MasterCare Data Warehouse for streamlined data analysis, e-switch middleware for seamless system integration, a Patient Portal for digital pre-admission data capture, and Altitude, their cloud hosting service.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

FRC's fair value estimate for Global Health Limited, and the rating behind it. GLH.AX last traded at AUD 0.07; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Global Health Limited. Starting points for Global Health Limited: EPS -AUD 0.01, beta -0.19 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Global Health Limited. Global Health Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Global Health Limited. Trailing twelve-month EPS for Global Health Limited stands at -AUD 0.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Global Health Limited. Global Health Limited has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Global Health Limited valued side by side against its closest peers. Global Health Limited is measured against Medical - Healthcare Information Services peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Which institutions hold Global Health Limited, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

Buying and selling by Global Health Limited executives and directors. Shares of Global Health Limited have traded between AUD 0.05 and AUD 0.14 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Global Health Limited. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Global Health Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Global Health Limited. Coverage tracks Global Health Limited within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • ACR.AX — Acrux Limited
  • ADR.AX — Adherium Limited
  • BIT.AX — Biotron Limited
  • CTQ.AX — Careteq Limited
  • HIQ.AX — HITIQ Limited
  • IBX.AX — Imagion Biosystems Limited
  • ICR.AX — Intelicare Holdings Limited

More Medical - Healthcare Information Services companies

  • VFX.AX — Visionflex Fpo [vfx]
  • VHI.TO — Vitalhub Corp.
  • VHIBF — Vitalhub Corp.
  • VHL.AX — Vitasora Health Limited
  • VRHI — Veri Medtech Holdings Inc.
  • VSEE — VSee Health, Inc.
  • VSEEW — VSee Health, Inc.
  • VYND — Vynleads, Inc.

News

Latest Market News